232 related articles for article (PubMed ID: 28694672)
21. Early detection of intrahepatic cholangiocarcinoma.
Hamaoka M; Kozaka K; Matsui O; Komori T; Matsubara T; Yoneda N; Yoshida K; Inoue D; Kitao A; Koda W; Gabata T; Kobayashi S
Jpn J Radiol; 2019 Oct; 37(10):669-684. PubMed ID: 31372893
[TBL] [Abstract][Full Text] [Related]
22. Quercetin Inhibits Intrahepatic Cholangiocarcinoma by Inducing Ferroptosis and Inhibiting Invasion via the NF-[Formula: see text]B Pathway.
Song Y; Zhang Z; Chai Q; Zheng H; Qi Y; Xia G; Yu Z; Yang R; Huang J; Li Y; Peng C; Jiang B; Liu S
Am J Chin Med; 2023; 51(3):701-721. PubMed ID: 36823098
[TBL] [Abstract][Full Text] [Related]
23. Molecular targeted and systemic therapy for intrahepatic cholangiocarcinoma: a multi-disciplinary approach.
Merath K; Tiwari A; Parikh AA; Pawlik TM
Future Oncol; 2023 Dec; 19(39):2607-2621. PubMed ID: 38108100
[TBL] [Abstract][Full Text] [Related]
24. A metastatic intrahepatic cholangiocarcinoma treated with programmed cell death 1 inhibitor: a case report and literature review.
Zhang J; Wu L; Liu J; Lin M
Immunotherapy; 2020 Jun; 12(8):555-561. PubMed ID: 32372672
[TBL] [Abstract][Full Text] [Related]
25. Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
Limousin W; Laurent-Puig P; Ziol M; Ganne-Carrié N; Nahon P; Ait-Omar A; Seror O; Sidali S; Campani C; Blanc P; Lermine A; Marisa L; Zucman-Rossi J; Nault JC
J Hepatol; 2023 Dec; 79(6):1450-1458. PubMed ID: 37647991
[TBL] [Abstract][Full Text] [Related]
26. Unmet needs in the treatment of intrahepatic cholangiocarcinoma harboring
Beri N
Future Oncol; 2022 Apr; 18(11):1391-1402. PubMed ID: 35081733
[TBL] [Abstract][Full Text] [Related]
27. EGFR, COX2, p-AKT expression and PIK3CA mutation in distal extrahepatic bile duct carcinoma.
Moon A; Chin S; Kim HK; Kwak JJ; Koh ES; Kim YW; Jang KT
Pathology; 2016 Jan; 48(1):35-40. PubMed ID: 27020207
[TBL] [Abstract][Full Text] [Related]
28. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
Borad MJ; Champion MD; Egan JB; Liang WS; Fonseca R; Bryce AH; McCullough AE; Barrett MT; Hunt K; Patel MD; Young SW; Collins JM; Silva AC; Condjella RM; Block M; McWilliams RR; Lazaridis KN; Klee EW; Bible KC; Harris P; Oliver GR; Bhavsar JD; Nair AA; Middha S; Asmann Y; Kocher JP; Schahl K; Kipp BR; Barr Fritcher EG; Baker A; Aldrich J; Kurdoglu A; Izatt T; Christoforides A; Cherni I; Nasser S; Reiman R; Phillips L; McDonald J; Adkins J; Mastrian SD; Placek P; Watanabe AT; Lobello J; Han H; Von Hoff D; Craig DW; Stewart AK; Carpten JD
PLoS Genet; 2014 Feb; 10(2):e1004135. PubMed ID: 24550739
[TBL] [Abstract][Full Text] [Related]
29. Alterations in DNA Damage Repair Genes in Primary Liver Cancer.
Lin J; Shi J; Guo H; Yang X; Jiang Y; Long J; Bai Y; Wang D; Yang X; Wan X; Zhang L; Pan J; Hu K; Guan M; Huo L; Sang X; Wang K; Zhao H
Clin Cancer Res; 2019 Aug; 25(15):4701-4711. PubMed ID: 31068370
[TBL] [Abstract][Full Text] [Related]
30. Molecular Profiling and Targeted Therapy in Cholangiocarcinoma: An Observational, Retrospective Multicenter Study.
Garcia-Pardo M; Ortega L; Fernández-Aceñero MJ; García Alfonso P; Martín M; Muñoz AJ
J Gastrointest Cancer; 2021 Jun; 52(2):814-818. PubMed ID: 33683644
[TBL] [Abstract][Full Text] [Related]
31. The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.
Chong DQ; Zhu AX
Oncotarget; 2016 Jul; 7(29):46750-46767. PubMed ID: 27102149
[TBL] [Abstract][Full Text] [Related]
32. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
[TBL] [Abstract][Full Text] [Related]
33. The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma.
Tang L; Tan YX; Jiang BG; Pan YF; Li SX; Yang GZ; Wang M; Wang Q; Zhang J; Zhou WP; Dong LW; Wang HY
Clin Cancer Res; 2013 Apr; 19(8):2014-24. PubMed ID: 23493353
[TBL] [Abstract][Full Text] [Related]
34. CT features of intraductal intrahepatic cholangiocarcinoma.
Lee JW; Han JK; Kim TK; Kim YH; Choi BI; Han MC; Suh KS; Kim SW
AJR Am J Roentgenol; 2000 Sep; 175(3):721-5. PubMed ID: 10954456
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon α-2b for advanced intrahepatic cholangiocarcinoma.
Kasai K; Kooka Y; Suzuki Y; Suzuki A; Oikawa T; Ushio A; Kasai Y; Sawara K; Miyamoto Y; Oikawa K; Takikawa Y
Ann Surg Oncol; 2014 Oct; 21(11):3638-45. PubMed ID: 24817369
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus and intrahepatic cholangiocarcinoma.
Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
[TBL] [Abstract][Full Text] [Related]
37. [Recent progress in molecular targeted therapies for intrahepatic cholangiocarcinoma].
Xie ZH; Li J; Xia Y; Shen F
Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):289-294. PubMed ID: 32241059
[TBL] [Abstract][Full Text] [Related]
38. [Radiological staging of hilar cholangiocarcinoma].
Byun JH
Korean J Gastroenterol; 2005 Jul; 46(1):7-15. PubMed ID: 16030398
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
[TBL] [Abstract][Full Text] [Related]
40. Liver transplantation for intrahepatic cholangiocarcinoma.
Hashimoto K; Miller CM
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):138-43. PubMed ID: 25214036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]